MARCO and neoplasm: Exactly, failed ICB therapy elicited higher surface MARCO on TAMs, which contributes to a trending increase of MARCO+ TAMs, highlighting the potential role of MARCO and MARCO+ TAMs in immune inhibition and tumor growth promotion.